Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Video: Interview With Sarah Frew Of Penn's Center For Innovation

Executive Summary

Formerly an executive with Genzyme and TetraLogic, Sarah Frew of the University of Pennsylvania's Center for Innovation spoke with "The Pink Sheet" at BioPharm America about the deal-making atmosphere between academia and private industry.

BOSTON – Formerly an executive with Genzyme Corp. and TetraLogic Pharmaceuticals Corp., Sarah Frew has headed up the University of Pennsylvania's Center for Innovation for more than a year. At the recent BioPharm America conference, she spoke with "The Pink Sheet" about the opportunities for collaboration between academic researchers and biopharma, as well as what Penn seeks in a potential partner.

BioPharm America 2015

Interview with Penn's Sarah Frew

Head of Penn's Center for Innovation Sarah Frew spoke with "The Pink Sheet" about academic/industry collaboration.

SOURCE: EBD Group

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS057173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel